Pfizer
Capitalisation boursière
$153.2B
Rang mondial
#115
Sommet historique
$265.1B
2021-12-31
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 69% of the 367 companies we track (globally).
- Equivalent to 0.5% of United States's GDP (2025 data).
- Just above: #114 Uber Technologies, Inc. ($153.2B)
- Just below: #116 Sony ($148.2B)
- Best year: 1997 (+82%). Worst year: 2023 (-41%).
Pfizer Financial Breakdown (FY 2025)
Source: Yahoo Finance — PFE annual filings (2025) →$62.6B revenue · $17.4B operating income · $7.8B net income
- ●Operating margin: 27.8% on $62.6B in revenue.
- ●R&D is 16.7% of revenue ($10.4B).
- ●Net income margin: 12.4% — $7.8B in profit.
- ●Free cash flow: $9.1B (14.5% of revenue).
Cost / Operating Expenses
Total operating expenses $45.2B
Total
$40.3B
Capital Expenditures
$2.6B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$9.1B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
À propos de Pfizer
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Historique de la capitalisation boursière de Pfizer (2026–2026)
Pfizer vs Sector Peers by Market Cap
Comparer Pfizer
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $153.2B | #115(↑1) | +11.5% |
| 2025 | $137.3B | #116(↓23) | +0.6% |
| 2024 | $136.4B | #93(↓20) | -2.2% |
| 2023 | $139.5B | #73(↓44) | -41.3% |
| 2022 | $237.5B | #29(↓1) | -10.4% |
| 2021 | $265.1B | #28(↑16) | +66.7% |
| 2020 | $159.1B | #44(↓11) | +3.1% |
| 2019 | $154.3B | #33(↓13) | -6.9% |
| 2018 | $165.8B | #20(↑8) | +24.8% |
| 2017 | $132.8B | #28 | +15.9% |
| 2016 | $114.6B | #28(↓4) | +4.4% |
| 2015 | $109.7B | #24(↑2) | +7.1% |
| 2014 | $102.5B | #26(↓2) | +5.3% |
| 2013 | $97.3B | #24(↑1) | +26.2% |
| 2012 | $77.1B | #25(↓3) | +20.4% |
| 2011 | $64.0B | #22(↑18) | +28.8% |
| 2010 | $49.7B | #40(↓10) | +0.3% |
| 2009 | $49.6B | #30(↓10) | +8.2% |
| 2008 | $45.8B | #20(↑13) | -17.0% |
| 2007 | $55.2B | #33(↓8) | -8.1% |
| 2006 | $60.1B | #25(↓5) | +15.3% |
| 2005 | $52.1B | #20(↓6) | -10.6% |
| 2004 | $58.3B | #14(↓4) | -22.3% |
| 2003 | $75.0B | #10 | +17.7% |
| 2002 | $63.7B | #10(↓2) | -22.2% |
| 2001 | $81.9B | #8(↓1) | -12.5% |
| 2000 | $93.5B | #7(↑3) | +43.1% |
| 1999 | $65.4B | #10(↓5) | -21.5% |
| 1998 | $83.3B | #5(↑3) | +68.9% |
| 1997 | $49.3B | #8(↑10) | +81.9% |
| 1996 | $27.1B | #18(↓1) | +34.0% |
| 1995 | $20.2B | #17(↑3) | +66.7% |
| 1994 | $12.1B | #20 |
Autres entreprises du secteur Santé
FAQ
What is Pfizer Inc.'s market cap?
Pfizer Inc. (PFE) has a market capitalization of $153.2B, making it the #115 largest company in the world by market cap.
What was Pfizer Inc.'s highest market cap?
Pfizer Inc.'s all-time high market cap was $265.1B, reached in 2021-12-31. Its highest rank was #28 in 2021.
What sector is Pfizer Inc. in?
Pfizer Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Pfizer Inc.'s market cap changed over time?
Pfizer Inc. has been tracked since 2026. Its market cap has grown by 0% from $153.2B in 2026 to $153.2B today.